Brian P. Kearney, PharmD
2022
In 2022, Brian P. Kearney, PharmD earned a total compensation of $1.9M as Chief Development Officer at PARDES BIOSCIENCES, a 215% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $161,800 |
|---|---|
| Option Awards | $1,257,473 |
| Salary | $433,000 |
| Total | $1,852,273 |
PharmD received $1.3M in option awards, accounting for 68% of the total pay in 2022.
PharmD also received $161.8K in non-equity incentive plan and $433K in salary.
Rankings
In 2022, Brian P. Kearney, PharmD's compensation ranked 1,882nd out of 5,756 executives tracked by ExecPay. In other words, PharmD earned more than 67.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,882 out of 5,756 | 67th |
Division Manufacturing | 994 out of 3,133 | 68th |
Major group Chemicals And Allied Products | 412 out of 1,419 | 71st |
Industry group Drugs | 377 out of 1,320 | 71st |
Industry Pharmaceutical Preparations | 271 out of 966 | 72nd |
Source: SEC filing on April 20, 2023.
PharmD's colleagues
We found three more compensation records of executives who worked with Brian P. Kearney, PharmD at PARDES BIOSCIENCES in 2022.